Unlabelled: Steroid therapy has been widely used in neonates for its beneficial effects. Adverse side-effects have been described, also affecting the cardiovascular system. We report two cases of hypertrophic cardiomyopathy in two preterm newborns secondary to dexamethasone treatment. Full recovery occurred after discontinuing steroids. Risk/benefit ratios must be carefully considered before using steroids in the neonatal period.
Conclusion: Serial echocardiographic evaluations should be performed to evaluate prevalence and clinical relevance of hypertrophic cardiomyopathy in preterm infants treated with dexamethasone.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s004310050623 | DOI Listing |
Publication Analysis
Top Keywords
hypertrophic cardiomyopathy
12
cardiomyopathy preterm
12
preterm infants
8
infants treated
8
treated dexamethasone
8
dexamethasone unlabelled
4
unlabelled steroid
4
steroid therapy
4
therapy neonates
4
neonates beneficial
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!